Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Persimmon Plc
Dechra Pharmaceuticals
Business
Jan 11 2024
4 min read

Dechra Pharmaceuticals

 


 

Further to the FTSE notice released on 09 January 2024 in relation to Dechra Pharmaceuticals (UK): Constituent Deletion,  please note the replacement in the fixed indices.

 

All other details remain unchanged. Please see updated notice below:

 

Dechra Pharmaceuticals (UK): Constituent Deletion - Update
Changes in FTSE UK Index Series

11 January 2024

Subject to court sanctioning the scheme of arrangement in relation to the cash offer for Dechra Pharmaceuticals (UK, constituent) by Freya Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

Dechra Pharmaceuticals (UK, 0963318) will be deleted from the index.

 

Persimmon PLC (UK, 0682538) will be added to the FTSE 100 Index and deleted from the FTSE 250 Index.

 

Baillie Gifford US Growth Trust (UK, BDFGHW4) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes effective from 16 January 2024

 

Full details of index changes are available on the FTSE Russell website.

 

 

 

 

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:


Australia


+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

                                   

 

Alternatively please visit our website at lseg.com/ftse-russell

 


 Terms of Use | Copyright © 2024 FTSE Russell